Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, announced the closing of a $11.75 million Series A financing round. The round was led by global pharmaceutical leader Octapharma AG, with additional participation from existing and new investors affiliated with University of Colorado Anschutz.